Issue 21, 2025

Engineered Mn–Zn-doped ferrite nanomaterials: exploring magnetothermal effects for cancer treatment

Abstract

The present work investigates the potential of Mn–Zn-doped ferrite (FMZ) nanoparticles for magnetic hyperthermia, focusing on the optimization of their magnetic characteristics to enhance their heat generation efficiency. The co-precipitation route was used to design FMZ (MnxZn1−xFe2O4) nanomaterials with x = 0, 0.25, 0.50, 0.75, and 1.0. Redshifts in their inverse spinel diffraction patterns confirmed the doping. Functional group analysis further verified the interactions of Zn and Mn within the ferrite lattice, while X-ray photoelectron spectroscopy (XPS) revealed their occupancy. The single-domain nature of the FMZ nanoparticles showed a spherical particle, with size varying linearly from 13.6 ± 2 to 15.7 ± 3 nm with an increase in the Mn content. Magnetic characterization revealed the linear relation of magnetization and Mn content with the superparamagnetic nature of the synthesized FMZ samples. The FMZ0.75 sample showed the highest magnetic saturation (MS) value of 38.90 emu g−1 among the FMZ samples. The specific absorption rate (SAR) values for the FMZ0.75 sample at 1, 3, and 5 mg mL−1 were 173.24, 107.12, and 105.42 W g−1, respectively. Notably, FMZ0.75 at 3 mg mL−1 reached hyperthermia temperature within 5 minutes. Furthermore, a peak function elucidated the interrelationship among particle size, MS, and SAR values, identifying an optimum particle size of 14.7 nm and an Mn fraction of 0.7. Cytocompatibility assays confirmed the suitability of FMZ samples against HEK-293 cells for the tested concentrations of up to 5 mg mL−1. Simulated hyperthermia studies revealed a significant reduction (35%) in the viability of the A549 cancer cell line, underlining the selective efficacy of FMZ nanomaterials. Considering the observed effective cytocompatibility and SAR values, FMZ samples can be effectively used for hyperthermia and related adjuvant therapy, such as chemotherapy for drug delivery applications.

Graphical abstract: Engineered Mn–Zn-doped ferrite nanomaterials: exploring magnetothermal effects for cancer treatment

Supplementary files

Article information

Article type
Paper
Submitted
28 Apr 2025
Accepted
11 Sep 2025
First published
11 Sep 2025
This article is Open Access
Creative Commons BY-NC license

Mater. Adv., 2025,6, 7981-7995

Engineered Mn–Zn-doped ferrite nanomaterials: exploring magnetothermal effects for cancer treatment

R. Fopase, K. P. Hazarika, J. P. Borah and L. M. Pandey, Mater. Adv., 2025, 6, 7981 DOI: 10.1039/D5MA00412H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements